150 related articles for article (PubMed ID: 36403192)
1. Evaluation of Longitudinal Lymphatic Function Changes upon Injury in the Mouse Tail with Photodynamic Therapy.
Kuzminich Y; Dixon JB
Cardiovasc Eng Technol; 2023 Apr; 14(2):204-216. PubMed ID: 36403192
[TBL] [Abstract][Full Text] [Related]
2. Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis.
Kilarski WW; Muchowicz A; Wachowska M; Mężyk-Kopeć R; Golab J; Swartz MA; Nowak-Sliwinska P
Angiogenesis; 2014 Apr; 17(2):347-57. PubMed ID: 23892627
[TBL] [Abstract][Full Text] [Related]
3. Regression of mature lymphatic vessels in the cornea by photodynamic therapy.
Bucher F; Bi Y; Gehlsen U; Hos D; Cursiefen C; Bock F
Br J Ophthalmol; 2014 Mar; 98(3):391-5. PubMed ID: 24414403
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic injury alters the contractility and mechanosensitivity of collecting lymphatics to intermittent pneumatic compression.
Mukherjee A; Nepiyushchikh Z; Michalaki E; Dixon JB
J Physiol; 2021 May; 599(10):2699-2721. PubMed ID: 33644884
[TBL] [Abstract][Full Text] [Related]
6. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
[TBL] [Abstract][Full Text] [Related]
9. Axial stretch regulates rat tail collecting lymphatic vessel contractions.
Razavi MS; Leonard-Duke J; Hardie B; Dixon JB; Gleason RL
Sci Rep; 2020 Apr; 10(1):5918. PubMed ID: 32246026
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
[TBL] [Abstract][Full Text] [Related]
11. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
Gross N; Ranjbar M; Evers C; Hua J; Martin G; Schulze B; Michaelis U; Hansen LL; Agostini HT
Mol Vis; 2013; 19():54-61. PubMed ID: 23335851
[TBL] [Abstract][Full Text] [Related]
12. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
13. Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization.
Lu F; Hu Z; Sinard J; Garen A; Adelman RA
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3890-6. PubMed ID: 19357351
[TBL] [Abstract][Full Text] [Related]
14. Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.
Matsubara A; Nakazawa T; Husain D; Iliaki E; Connolly E; Michaud NA; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2498-507. PubMed ID: 16723462
[TBL] [Abstract][Full Text] [Related]
15. Investigation of cell death mechanisms in human lymphatic endothelial cells undergoing photodynamic therapy.
Wachowska M; Osiak A; Muchowicz A; Gabrysiak M; Domagała A; Kilarski WW; Golab J
Photodiagnosis Photodyn Ther; 2016 Jun; 14():57-65. PubMed ID: 26868051
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice.
Muchowicz A; Wachowska M; Stachura J; Tonecka K; Gabrysiak M; Wołosz D; Pilch Z; Kilarski WW; Boon L; Klaus TJ; Golab J
Eur J Cancer; 2017 Sep; 83():19-27. PubMed ID: 28709135
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic remodelling in response to lymphatic injury in the hind limbs of sheep.
Nelson TS; Nepiyushchikh Z; Hooks JST; Razavi MS; Lewis T; Clement CC; Thoresen M; Cribb MT; Ross MK; Gleason RL; Santambrogio L; Peroni JF; Dixon JB
Nat Biomed Eng; 2020 Jun; 4(6):649-661. PubMed ID: 31873209
[TBL] [Abstract][Full Text] [Related]
18. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.
Chan WM; Lam DS; Lai TY; Tam BS; Liu DT; Chan CK
Br J Ophthalmol; 2003 Dec; 87(12):1453-8. PubMed ID: 14660450
[TBL] [Abstract][Full Text] [Related]
19. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.
Opitz I; Krueger T; Pan Y; Altermatt HJ; Wagnières G; Ris HB
Eur Surg Res; 2006; 38(3):333-9. PubMed ID: 16785733
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment.
Lu J; Roy B; Anderson M; Leggett CL; Levy MJ; Pogue B; Hasan T; Wang KK
J Biomed Opt; 2019 Nov; 24(11):1-11. PubMed ID: 31741351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
